1. Home
  2. BVS vs NATH Comparison

BVS vs NATH Comparison

Compare BVS & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • NATH
  • Stock Information
  • Founded
  • BVS 2011
  • NATH 1916
  • Country
  • BVS United States
  • NATH United States
  • Employees
  • BVS N/A
  • NATH N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NATH Restaurants
  • Sector
  • BVS Health Care
  • NATH Consumer Discretionary
  • Exchange
  • BVS Nasdaq
  • NATH Nasdaq
  • Market Cap
  • BVS 448.8M
  • NATH 442.2M
  • IPO Year
  • BVS 2021
  • NATH N/A
  • Fundamental
  • Price
  • BVS $6.67
  • NATH $107.95
  • Analyst Decision
  • BVS Strong Buy
  • NATH
  • Analyst Count
  • BVS 4
  • NATH 0
  • Target Price
  • BVS $13.75
  • NATH N/A
  • AVG Volume (30 Days)
  • BVS 291.4K
  • NATH 32.5K
  • Earning Date
  • BVS 11-04-2025
  • NATH 11-06-2025
  • Dividend Yield
  • BVS N/A
  • NATH 1.86%
  • EPS Growth
  • BVS N/A
  • NATH 9.62
  • EPS
  • BVS 0.03
  • NATH 5.77
  • Revenue
  • BVS $564,142,000.00
  • NATH $150,413,000.00
  • Revenue This Year
  • BVS N/A
  • NATH N/A
  • Revenue Next Year
  • BVS $6.88
  • NATH N/A
  • P/E Ratio
  • BVS $237.41
  • NATH $18.12
  • Revenue Growth
  • BVS 5.08
  • NATH 6.38
  • 52 Week Low
  • BVS $5.81
  • NATH $75.15
  • 52 Week High
  • BVS $14.38
  • NATH $118.50
  • Technical
  • Relative Strength Index (RSI)
  • BVS 45.07
  • NATH 52.61
  • Support Level
  • BVS $6.37
  • NATH $103.38
  • Resistance Level
  • BVS $6.83
  • NATH $109.15
  • Average True Range (ATR)
  • BVS 0.25
  • NATH 2.58
  • MACD
  • BVS -0.02
  • NATH -0.36
  • Stochastic Oscillator
  • BVS 44.63
  • NATH 49.36

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: